NCT01152567 Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension Status COMPLETED Phase N/A
NCT01152554 A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01152385 Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients Status COMPLETED Phase PHASE2
NCT01151215 Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer Status TERMINATED Phase PHASE2
NCT01150812 Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects Status TERMINATED Phase PHASE1
NCT01148095 To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01147666 Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis Status COMPLETED Phase PHASE2
NCT01147588 Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel Status COMPLETED Phase PHASE1
NCT01147549 Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01146392 An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT01145768 To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days Status COMPLETED Phase PHASE1
NCT01145755 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder Status TERMINATED Phase PHASE2
NCT01145560 A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock Status COMPLETED Phase PHASE2
NCT01144624 A Study to Assess Safety,and Tolerability of 2 Doses of AZD9773 (CytoFab™) in Japanese With Severe Sepsis/Septic Shock Status COMPLETED Phase PHASE2
NCT01144572 Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment Status COMPLETED Phase N/A
NCT01144481 Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases Status COMPLETED Phase N/A
NCT01144338 Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3